(7) applied WES on 73 advanced NSCLC tumor samples and demonstrated Protein tyrosine phosphatase receptor type D (PTPRD) might be both a prognostic and a predictive biomarker predicting clinical outcomes in non-squamous (ns)-NSCLC patients. This evidence concerns the gene PTPRD and non-small cell lung carcinoma.